Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone for acute pain and anxiety after gynecological surgery
ChiCTR2200062408Phase 4Not yet recruiting
- Sponsor
- Xiangyang Central Hospital
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oxycodone in postoperative pain and anxiety disorder (2 arms), sponsored by Xiangyang Central Hospital. Primary endpoints: Postoperative pain score (NRS) and Postoperative anxiety (Zung Self-Rating Anxiety Scale, SAS). Planned start Aug 2022; status: not yet recruiting.
02
Drugs
oxycodone
03
Conditions
postoperative painanxiety disorder
Beyond the preview
Go deeper on ChiCTR2200062408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062408.